Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Gerard, Karen
1993.
Setting priorities in the new NHS: can purchasers use cost-utility information?.
Health Policy,
Vol. 25,
Issue. 1-2,
p.
109.
Olsen, Jan Abel
1993.
Time preferences for health gains: An empirical investigation.
Health Economics,
Vol. 2,
Issue. 3,
p.
257.
DRUMMOND, M. F.
McGUIRE, A. J.
BLACK, N. A.
PETTICREW, M.
and
McPHERSON, C. K.
1993.
Economic Burden of Treated Benign Prostatic Hyperplasia in the United Kingdom.
British Journal of Urology,
Vol. 71,
Issue. 3,
p.
290.
Drummond, Michael
Torrance, George
and
Mason, James
1993.
Cost-effectiveness league tables: More harm than good?.
Social Science & Medicine,
Vol. 37,
Issue. 1,
p.
33.
Olsen, Jan Abel
1993.
On what basis should health be discounted?.
Journal of Health Economics,
Vol. 12,
Issue. 1,
p.
39.
Gerard, Karen
and
Mooney, Gavin
1993.
Qaly league tables: Handle with care.
Health Economics,
Vol. 2,
Issue. 1,
p.
59.
Allander, E.
Lindahl, B.I.B.
Dilsen, G.
Gennari, C.
Vaz, A.A.Lopez
Lyritis, G.
Mazzuoli, G.D.
Miravet, L.
Passeri, M.
Cano, R.Perez
Rapado, A.
Ribot, C.
Allander, E.
Dequeker, J.
Gonzales, A.
Kanis, J.A.
Khaltaev, N.
and
Plüss, M.
1993.
The mediterranean osteoporosis study (MEDOS): Theoretical and practical issues of a major international project on hip fracture epidemiology.
Bone,
Vol. 14,
Issue. ,
p.
37.
Drummond, Michael
1994.
Evaluation of health technology: Economic issues for health policy and policy issues for economic appraisal.
Social Science & Medicine,
Vol. 38,
Issue. 12,
p.
1593.
Olsen, Jan Abel
1994.
PRODUCTION GAINS: SHOULD THEY COUNT IN HEALTH CARE EVALUATIONS?.
Scottish Journal of Political Economy,
Vol. 41,
Issue. 1,
p.
69.
Briggs, Andrew
Sculpher, Mark
and
Buxton, Martin
1994.
Uncertainty in the economic evaluation of health care technologies: The role of sensitivity analysis.
Health Economics,
Vol. 3,
Issue. 2,
p.
95.
Souĕtre, E.
Lozet, H.
Cimarosti, I.
Martin, P.
Chignon, J.M.
Adés, J.
Tignol, J.
and
Darcourt, G.
1994.
Cost of anxiety disorders: Impact of comorbidity.
Journal of Psychosomatic Research,
Vol. 38,
Issue. ,
p.
151.
Gibaldi, Milo
and
Sullivan, Sean D.
1994.
A Look at Cost‐Effectiveness.
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy,
Vol. 14,
Issue. 4,
p.
399.
Rutten‐van Mölken, Maureen P. M. H.
Van, Eddy K. A.
and
van Vliet, René C. J. A.
1994.
Statistical analysis of cost outcomes in a randomized controlled clinical trial.
Health Economics,
Vol. 3,
Issue. 5,
p.
333.
Clark, Robin E.
Teague, Gregory B.
Ricketts, Susan K.
Bush, Philip W.
Keller, Adam M.
Zubkoff, Michael
and
Drake, Robert E.
1994.
Measuring resource use in economic evaluations: Determining the social costs of mental illness.
The Journal of Mental Health Administration,
Vol. 21,
Issue. 1,
p.
32.
Jefferson, Tom
and
Demicheli, Vittorio
1994.
Is vaccination against hepatitis b efficient? A review of world literature.
Health Economics,
Vol. 3,
Issue. 1,
p.
25.
Sculpher, M.J.
Buxton, M.J.
Seed, P.
Pocock, S.J.
Henderson, R.A.
Parker, J.
Joy, M.D.
Sowton, E.
Hampton, J.R.
and
for RITA trial participants
1994.
Health service costs of coronary angioplasty and coronary artery bypass surgery: the Randomised Intervention Treatment of Angina (RITA) trial.
The Lancet,
Vol. 344,
Issue. 8927,
p.
927.
Hutton, John
1994.
Economic Evaluation of healthcare: A half‐way technology.
Health Economics,
Vol. 3,
Issue. 1,
p.
1.
Leidl, Reiner M.
1994.
Some Factors to Consider when Using the Results of Economic Evaluation Studies at the Population Level.
International Journal of Technology Assessment in Health Care,
Vol. 10,
Issue. 3,
p.
467.
Rovira, Joan
1994.
Standardizing economic appraisal of health technology in the European community.
Social Science & Medicine,
Vol. 38,
Issue. 12,
p.
1675.
Olsen, Jan Abel
1994.
Persons vs years: Two ways of eliciting implicit weights.
Health Economics,
Vol. 3,
Issue. 1,
p.
39.